Clinical trial · Interventional
Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
Randomized Sham Controlled Trial of Weekly Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy
NCT01163682CI-TRIAL-00069756completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study seeks to determine if 12 weeks of weekly electro-acupuncture will prevent or decrease neuropathic pain in breast cancer patients receiving 12 weekly treatments of taxane treatment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Neuropathy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Electro-acupuncture | Device | — | UNRESOLVED |
| Sham acupuncture | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Electro-acupuncture
- description
- Subjects will receive 45 minute sessions scheduled once a week for 12 weeks with electro-acupuncture.
- interventionNames
- Device: Electro-acupuncture
- type
- SHAM_COMPARATOR
- label
- Sham acupuncture
- description
- Subjects will receive 45 minute sessions scheduled once a week for 12 weeks with sham acupuncture.
- interventionNames
- Device: Sham acupuncture
Primary outcomes (1)
- measure
- Change in Brief Pain Inventory-Short Form Score
- timeFrame
- Baseline, 16 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Age\>21 years * History of stage I-III breast cancer * Patient scheduled to be receiving weekly adjuvant or neo-adjuvant paclitaxel for 12 weeks * Signed informed consent Exclusion Criteria: * Previous treatment with acupuncture in the last 12 months * Diabetic Neuropathy or other neurological conditions * Inflammatory, metabolic or neuropathic arthropathies * Current narcotic use * Severe concomitant illnesses * Severe coagulopathy or bleeding disorder * Dermatological disease within the acupuncture area * Have a pacemaker
References
Publications (0)
Data not yet available
No reference posted for this study.